Analysis of the Efficiency of Microencapsulated Sustained-Release Form of Naloxone on the Experimental Model of Fentanyl Poisoning


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

We compared samples of microencapsulated naloxone prepared by using spray drying technique. 2-Hydroxypropyl-β-cyclodextrin, sodium alginate, polycaprolactone, and carboxymethyl cellulose were used as the carriers. It was found that the combination of naloxone with sodium alginate was characterized by the highest naloxone content in the matrix and the lowest release rate (100% release time was 60 min). Using the model of respiratory disturbances caused by 10 ED50 fentanyl (anesthetic effect), we studied the effects of naloxone—sodium alginate complex on the dynamics of CO2 concentration in the expired air. It was shown that treatment with the developed microencapsulated naloxone after fentanyl injection allowed reducing the therapeutic dose of the antagonist by more than 2 times and eliminated the necessity of repeated injections.

About the authors

N. G. Vengerovich

State Research Testing Institute of Military Medicine, Ministry of Defense of the Russian Federation

Author for correspondence.
Email: ng@vengerovich.ru
Russian Federation, Moscow

M. A. Yudin

State Research Testing Institute of Military Medicine, Ministry of Defense of the Russian Federation

Email: ng@vengerovich.ru
Russian Federation, Moscow

V. N. Bykov

State Research Testing Institute of Military Medicine, Ministry of Defense of the Russian Federation

Email: ng@vengerovich.ru
Russian Federation, Moscow

A. S. Nikiforov

State Research Testing Institute of Military Medicine, Ministry of Defense of the Russian Federation

Email: ng@vengerovich.ru
Russian Federation, Moscow

O. I. Aleshina

State Research Testing Institute of Military Medicine, Ministry of Defense of the Russian Federation

Email: ng@vengerovich.ru
Russian Federation, Moscow

A. A. Kuz’min

State Research Testing Institute of Military Medicine, Ministry of Defense of the Russian Federation

Email: ng@vengerovich.ru
Russian Federation, Moscow

T. M. Ustinova

State Research Testing Institute of Military Medicine, Ministry of Defense of the Russian Federation

Email: ng@vengerovich.ru
Russian Federation, Moscow

S. V. Gadzikovskii

Silver-Farm Innovative Pharmaceutical Companyss

Email: ng@vengerovich.ru
Russian Federation, St. Petersburg


Copyright (c) 2017 Springer Science+Business Media, LLC

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies